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Introduction: Medication review and polypharmacy management, especially in the elderly, are 
key components of integrated care. Although polypharmacy management is often associated 
with the primary care setting, hospital clinicians, who are often members of multidisciplinary 
therapeutic teams, have an opportunity to improve the management of polypharmacy, which 
has the potential to improve health outcomes in both hospital and primary care. 
Methods: Mixed-methods (desk reviews, key informant interviews and focus groups) case 
studies were carried out in Greece and Catalonia, in the framework of  the  SIMPATHY 
(Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) project, 
in order to describe policies and procedures on the management of polypharmacy and 
adherence in the elderly and describe implementation strategies. Kotter’s Eight Step Process 
for transforming change and normalization process theory (NPT) were applied both in data 
collection tools and in the analysis. 
Progress report: At both sites there was awareness regarding the need for management of 
polypharmacy in the elderly, although in Greece awareness had not translated to a sense of 
urgency, a critical early step in Kotter’s process. Barriers to implementation in Greece included 
extreme financial pressure, lack or organizational culture supporting multidisciplinary teams 
and shared decision making, and lack of guidance from central health authorities. However, 
despite the lack of national guidelines, hospital pharmacists in state (public) hospitals 
currently review medication for inpatients and out-patients, and interventions regarding 
inappropriate polypharmacy and reconciliation of care have been piloted. In Catalonia, 
implementation of an Institutional network sponsored model has been implemented and it is 
being evaluated. Polypharmacy was integrated as a specific component of a broader patient-
centered service model, driven by a small multidisciplinary team, with a focus on global health 
outcomes. Facilitators, to implementation included an organizational culture of innovation and 
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shared decision making, advanced training requirements of all hospital pharmacists, and 
regional health policies focusing on improved care for patients with complex chronic disease. 
Conclusion and future work: Although Greece is a country with no programme of polypharmacy 
management identified, there are some policies and clinical activities in place that could 
support future programmes.  National guidance will ultimately be needed to mobilize health 
professionals and ensure consistency of care.  The Catalan experience demonstrates that 
polypharmacy management can occur in the hospital setting.  Future challenges include scaling 
the current model into other units within the hospital and into primary care. Given the 
pharmacist training and current medicines management activities in Greece, the hospital may 
be an appropriate entry point for polypharmacy management activities in that country, later 
scaling up to the community.  As other health systems look to address polypharmacy, hospital 
should be considered a potential starting point for initiating a programme.  
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